A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2− Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence.

Simple Summary: Drugs known as cyclin-dependent kinase 4/6 inhibitors are commonly used together with hormone therapy as the first treatment for people with hormone receptor-positive, HER2-negative advanced breast cancer. However, these drugs have not been directly compared in large clinical trials....

Descripción completa

Detalles Bibliográficos

Publicado en:	Cancers Vol. 18; no. 14; pp. 2362 - 2385
Autores principales:	Pluard, Timothy, Grinda, Thomas, Dienstmann, Rodrigo, Thill, Marc, Korytowsky, Beata, Chen, Connie, Portuhay, Sofiya, Salvo-Halloran, Elizabeth M., Samjoo, Imtiaz A., Harbeck, Nadia
Formato:	research systematic review tables/charts Journal Article
Publicado:	MDPI Jul2026
Acceso en línea:	Ver este registro en EBSCOhost